Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines

Journal of Virological Methods

Volumn 171, Issue 1, 2011, Pages 53-60

  van Wielink, R ^a   Kant Eenbergen, H C M ^a   Harmsen, M M ^a   Martens, D E ^a   Wijffels, R H ^a   Coco Martin, J M ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Lelystad Biologicals BV   (Netherlands)

Author keywords

Cell culture; Suspension growth; Veterinary vaccine production

Indexed keywords

ALPHA 2,3 SIALIC ACID RECEPTOR; ALPHA 2,6 SIALIC ACID RECEPTOR; HEMAGGLUTININ; SIALIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL CELL; ARTICLE; AVIAN INFLUENZA VIRUS; CELL GROWTH; CELL POPULATION; CELL STRAIN BHK; CELL SUSPENSION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; KIDNEY CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; VERO CELL; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; CULTURE MEDIA, SERUM-FREE; DOGS; INFLUENZA A VIRUS; VIROLOGY;

AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE; SANDFLY FEVER SICILIAN VIRUS;

EID: 78650569516     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.09.029     Document Type: Article

References (33)

1. Almond J.W. A single gene determines the host range of influenza virus. Nature 1977, 270:617-618.
2. Audsley J.M., Tannock G.A. The growth of attenuated influenza vaccine donor strains in continuous cell lines. J. Virol. Methods 2005, 123:187-193.
3. Bouvier N.M., Palese P. The biology of influenza viruses. Vaccine 2008, 26(Suppl. 4):D49-53.
4. Chu C., Lugovtsev V., Golding H., Betenbaugh M., Shiloach J. Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:14802-14807.
5. Dugan A.S., Eash S., Atwood W.J. An N-linked glycoprotein with alpha(2,3)-linked sialic acid is a receptor for BK virus. J. Virol. 2005, 79:14442-14445.
6. Ellis T.M., Leung C.Y., Chow M.K., Bissett L.A., Wong W., Guan Y., Malik Peiris J.S. Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission. Avian Pathol. 2004, 33:405-412.
7. Emoto Y. Cellular aggregation facilitates anoikis in MDCK cells. J. Physiol. Sci. 2008, 58:371-380.
8. Genzel Y., Fischer M., Reichl U. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Vaccine 2006, 24:3261-3272.
9. Genzel Y., Olmer R.M., Schafer B., Reichl U. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Vaccine 2006, 24:6074-6087.
10. Genzel Y., Reichl U. Continuous cell lines as a production system for influenza vaccines. Expert Rev. Vaccines 2009, 8:1681-1692.
11. Govorkova E.A., Kaverin N.V., Gubareva L.V., Meignier B., Webster R.G. Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero). J. Infect. Dis. 1995, 172:250-253.
12. Govorkova E.A., Kodihalli S., Alymova I.V., Fanget B., Webster R.G. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs. Dev. Biol. Stand. 1999, 98:39-51.
13. Govorkova E.A., Matrosovich M.N., Tuzikov A.B., Bovin N.V., Gerdil C., Fanget B., Webster R.G. Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells. Virology 1999, 262:31-38.
14. Groner, A., Vorlop, J., 1997. Animal cells and processes for the replication of influenza viruses. Patent WO 97/37000.
15. Kalbfuss B., Knochlein A., Krober T., Reichl U. Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity. Biologicals 2008, 36:145-161.
16. Kaverin N.V., Webster R.G. Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity. J. Virol. 1995, 69:2700-2703.
17. Kistner O., Barrett P.N., Mundt W., Reiter M., Schober-Bendixen S., Dorner F. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 1998, 16:960-968.
18. Liu J., Mani S., Schwartz R., Richman L., Tabor D.E. Cloning and assessment of tumorigenicity and oncogenicity of a Madin-Darby canine kidney (MDCK) cell line for influenza vaccine production. Vaccine 2010, 28:1285-1293.
19. Liu J., Shi X., Schwartz R., Kemble G. Use of MDCK cells for production of live attenuated influenza vaccine. Vaccine 2009, 27:6460-6463.
20. Lohr V., Rath A., Genzel Y., Jordan I., Sandig V., Reichl U. New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation. Vaccine 2009, 27:4975-4982.
21. Maas R., Tacken M., van Zoelen D., Oei H. Dose response effects of avian influenza (H7N7) vaccination of chickens: serology, clinical protection and reduction of virus excretion. Vaccine 2009, 27:3592-3597.
22. Mazurkova N.A., Troshkova G.P., Sumkina T.P., Kolokol'tsova T.D., Skarnovich M.O., Kabanov A.S., Shishkina L.N., Sergeev A.N. Comparative analysis of reproduction of influenza virus strains in cell lines perspective for the creation of cultural vaccines grown on nutrient medium on the basis of rise flour protein hydrolysate. Bull. Exp. Biol. Med. 2008, 146:547-550.
23. Mehtali, M., Champion-Arnaud, P., Arnaud, L., 2006. Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines. Patent WO2006108846.
24. Merten O.W., Manuguerra J.C., Hannoun C., van der Werf S. Production of influenza virus in serum-free mammalian cell cultures. Dev. Biol. Stand. 1999, 98:23-37.
25. Mohler L., Flockerzi D., Sann H., Reichl U. Mathematical model of influenza A virus production in large-scale microcarrier culture. Biotechnol. Bioeng. 2005, 90:46-58.
26. Pau M.G., Ophorst C., Koldijk M.H., Schouten G., Mehtali M., Uytdehaag F. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 2001, 19:2716-2721.
27. Peshwa M.V., Kyung Y.S., McClure D.B., Hu W.S. Cultivation of mammalian cells as aggregates in bioreactors: effect of calcium concentration of spatial distribution of viability. Biotechnol. Bioeng. 1993, 41:179-187.
28. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 1938, 27:493-497.
29. Schulze-Horsel J., Schulze M., Agalaridis G., Genzel Y., Reichl U. Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-flow cytometry and mathematical modeling. Vaccine 2009, 27:2712-2722.
30. Sorrell E.M., Ramirez-Nieto G.C., Gomez-Osorio I.G., Perez D.R. Genesis of pandemic influenza. Cytogenet. Genome Res. 2007, 117:394-402.
31. Tree J.A., Richardson C., Fooks A.R., Clegg J.C., Looby D. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine 2001, 19:3444-3450.
32. Tsutsumi R., Fujisaki S., Shozushima M., Saito K., Sato S. Anoikis-resistant MDCK cells carrying susceptibilities to TNF-α and verotoxin that are suitable for influenza virus cultivation. Cytotechnology 2006, 52:71-85.
33. Wang A.Z., Ojakian G.K., Nelson W.J. Steps in the morphogenesis of a polarized epithelium. I. Uncoupling the roles of cell-cell and cell-substratum contact in establishing plasma membrane polarity in multicellular epithelial (MDCK) cysts. J. Cell Sci. 1990, 95(Pt 1):137-151.